{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:06:22Z","timestamp":1783670782605,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.brachy.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T21:05:08Z","timestamp":1513803908000},"page":"399-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma"],"prefix":"10.1016","volume":"17","author":[{"given":"John M.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Damast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Bledsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataniel H.","family":"Lester-Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.11.012_bib1","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.012_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib3","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2017.11.012_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2016.10.028","article-title":"Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis","volume":"144","author":"Gupta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.11.012_bib6","first-page":"816","article-title":"ACR appropriateness criteria(R) adjuvant management of early-stage endometrial cancer","volume":"30","author":"Wahl","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.brachy.2017.11.012_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2013the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.brachy.2017.11.012_bib8","volume":"Volume 64","author":"Xu","year":"2016"},{"key":"10.1016\/j.brachy.2017.11.012_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.11.012_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer","volume":"116","author":"Lewin","year":"2010","journal-title":"Obstetrics Gynecol"},{"key":"10.1016\/j.brachy.2017.11.012_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0360-3016(89)90366-0","article-title":"Results of radiotherapy in recurrent endometrial carcinoma: A retrospective analysis of 51 patients","volume":"17","author":"Kuten","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.012_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(00)00642-8","article-title":"Recurrent endometrial cancer after surgery alone: Results of salvage radiotherapy","volume":"48","author":"Jereczek-Fossa","year":"2000","journal-title":"Int J Radiat Oncology Biology Phys"},{"key":"10.1016\/j.brachy.2017.11.012_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0360-3016(88)90110-1","article-title":"Vaginal recurrences of endometrial carcinoma: The prognostic value of staging by a primary vaginal carcinoma system","volume":"15","author":"Curran","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.012_bib14","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.012_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1525-1438.2007.00858.x","article-title":"Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: A multiinstitutional experience","volume":"17","author":"Huh","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.11.012_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: Results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/1097-0142(19940815)74:4<1303::AID-CNCR2820740420>3.0.CO;2-G","article-title":"Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer","volume":"74","author":"Sears","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2017.11.012_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/gyno.2000.5727","article-title":"Results of radical radiotherapy for recurrent endometrial cancer","volume":"77","author":"Wylie","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/gyno.1999.5536","article-title":"Pelvic exenteration for recurrent endometrial cancer","volume":"75","author":"Barakat","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib20","first-page":"403","article-title":"Vaginal and pelvic recurrences in stage I and II endometrial carcinoma\u2013survival and prognostic factors","volume":"32","author":"Blecharz","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2011.09.031","article-title":"Pelvic exenteration with curative intent for recurrent uterine malignancies","volume":"124","author":"Khoury-Collado","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2013.07.385","article-title":"Development and evaluation of the universal ACS NSQIP surgical risk calculator: A decision aid and informed consent tool for patients and surgeons","volume":"217","author":"Bilimoria","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.brachy.2017.11.012_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2007.08.072","article-title":"A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma","volume":"108","author":"Lachance","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib24","unstructured":"DIRECTREES Coding Help Application. Churchill Consulting;\u00a02016."},{"key":"10.1016\/j.brachy.2017.11.012_bib25","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2014.14950","article-title":"Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer","volume":"312","author":"Obermeyer","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2017.11.012_bib26","unstructured":"ICD-10-CM\/PCS MS-DRG v34.0. Definitions Manual. Centers for Medicare & Medicaid Services.\u00a02016."},{"key":"10.1016\/j.brachy.2017.11.012_bib27","unstructured":"ASP Pricing File Payment Allowance Limits for Medicare Part B Drugs. cms.gov;\u00a02016."},{"key":"10.1016\/j.brachy.2017.11.012_bib28","series-title":"Medicare Coding & Payment for Drug Administration Services under the Physician Fee Schedule","year":"2016"},{"key":"10.1016\/j.brachy.2017.11.012_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2007.04.015","article-title":"Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer","volume":"106","author":"Rankins","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2004.03.002","article-title":"Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: Postoperative brachytherapy vs. observation","volume":"93","author":"Fanning","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.012_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2017.11.012_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2016.06.012","article-title":"Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data","volume":"15","author":"Modh","year":"2016","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:36Z","timestamp":1761531216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117305330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1538472117305330"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.012","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}